RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Updates are delayed or unverified. Check original sources for the latest information.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD Q93.5ORPHA:72AS

Angelman Syndrome

Angelman syndrome is a genetic condition affecting the nervous system that causes severe intellectual disability, speech difficulties, seizures, and a characteristically happy, excitable personality. It is caused by a missing or non-working UBE3A gene. Research into gene therapy and UBE3A-targeted treatments is progressing rapidly.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

505
Articles
27
Trials (7 AU)
Data refreshed
19 October 2026
Loading...

Common Questions

What is Angelman Syndrome?

Angelman syndrome is a genetic condition affecting the nervous system that causes severe intellectual disability, speech difficulties, seizures, and a characteristically happy, excitable personality. It is caused by a missing or non-working UBE3A gene. Research into gene therapy and UBE3A-targeted treatments is progressing rapidly.

How many clinical trials are available for Angelman Syndrome?

RareWays currently indexes 27 clinical trials for Angelman Syndrome, of which 3 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.

Where does the research data for Angelman Syndrome come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Angelman Syndrome.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.